These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Antisynthetase syndrome: a report of four cases and literature review]. Frikha F, Saidi N, Snoussi M, Ben Salah R, Ben Ayed M, Daoud E, Hentati Y, Makni S, Mnif Z, Boudawara T, Masmoudi H, Bahloul Z. Rev Pneumol Clin; 2012 Dec; 68(6):351-60. PubMed ID: 23062471 [Abstract] [Full Text] [Related]
13. Antisynthetase Syndrome: A Rare Cause for ILD. Devi HG, Pasha MM, Padmaja MS, Halappa S. J Clin Diagn Res; 2016 Mar; 10(3):OD08-9. PubMed ID: 27134916 [Abstract] [Full Text] [Related]
14. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease. Patel P, Marinock JM, Ajmeri A, Brent LH. Int J Mol Sci; 2024 Apr 18; 25(8):. PubMed ID: 38674039 [Abstract] [Full Text] [Related]
15. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience. Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B. Immun Inflamm Dis; 2023 Nov 18; 11(11):e1085. PubMed ID: 38018600 [Abstract] [Full Text] [Related]
16. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group. Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA, AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group. Clin Rev Allergy Immunol; 2017 Feb 18; 52(1):71-80. PubMed ID: 26782036 [Abstract] [Full Text] [Related]
17. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F. Autoimmun Rev; 2012 Aug 18; 11(10):739-45. PubMed ID: 22326685 [Abstract] [Full Text] [Related]
18. The long-term outcome of anti-Jo-1-positive inflammatory myopathies. Späth M, Schröder M, Schlotter-Weigel B, Walter MC, Hautmann H, Leinsinger G, Pongratz D, Müller-Felber W. J Neurol; 2004 Jul 18; 251(7):859-64. PubMed ID: 15258790 [Abstract] [Full Text] [Related]
19. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome. Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S. Eur J Intern Med; 2013 Jul 18; 24(5):474-9. PubMed ID: 23375620 [Abstract] [Full Text] [Related]
20. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, Cherin P, Mouthon L, Vittecoq O, Menard JF, Jouen F. Arthritis Care Res (Hoboken); 2013 May 18; 65(5):800-8. PubMed ID: 23203765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]